Silva M A, Tekin K, Aytekin F, Bramhall S R, Buckels J A C, Mirza D F
The Liver Unit, Queen Elizabeth Hospital, University Hospital Birmingham NHS Trust, 3rd Floor, Nuffield House, Edgbaston, Birmingham B15 2TH, UK.
Eur J Surg Oncol. 2005 Jun;31(5):533-9. doi: 10.1016/j.ejso.2005.02.021. Epub 2005 Apr 26.
To review the outcome of patients operated for hilar cholangiocarcinoma and analyse prognostic variables.
A prospectively collected database on patients with hilar cholangiocarcinoma, between 1992 and 2003, and relevant clinical notes were reviewed retrospectively. A total of 174 patients, 96 male, median age 63 years (27-86), were referred. Jaundice was the initial presentation in 167.
ERCP was the initial interventional investigation at the referring centre in 150, of which only 30 were stented successfully. PTC and decompression was carried out on 120. In 17, combined PTC and ERCP were required for placement of stents. Seventy-two underwent laparotomy at which 27 had locally advanced disease. Forty-five had potentially curative resections. Extra hepatic bile duct resection was done in 14 patients of which four were R0 resections. Thirty-one had bile duct resection including partial hepatectomy with 19 R0 resections (P=0.042). Post-operative complications developed in 19 patients, and there were 4 30 day mortalities [hepatic insufficiency:/sepsis (n=3), thrombosis of the reconstructed portal vein (n=1)]. Among the patients with R0 resections, the cumulative survival rates at 1, 3, and 5 year; was 83, 58, 41%, respectively, and in those with R1 resections were 71, 24, 24%, respectively, (P=0.021). Overall survival was shorter in patients with positive perineural invasion (P=0.066: NS). There was no significant difference in survival between the node positive and negative group. Median survival of patients who underwent liver resection was longer than those with bile duct resection only (30 vs 24 months P=0.43: NS).
ERCP was associated with a high failure rate in achieving pre-operative biliary decompression which was subsequently achieved by PTC. Clear histological margins were associated with improved survival and were better achieved by liver resection as compared to extra hepatic bile duct resection. Positive level I lymph nodes did not adversely impact survival.
回顾肝门部胆管癌手术患者的治疗结果并分析预后变量。
回顾性分析1992年至2003年间前瞻性收集的肝门部胆管癌患者数据库及相关临床记录。共纳入174例患者,男性96例,中位年龄63岁(27 - 86岁)。167例患者以黄疸为首发症状。
150例患者在转诊中心接受的初始介入检查为内镜逆行胰胆管造影(ERCP),其中仅30例成功置入支架。120例患者接受了经皮肝穿刺胆管造影(PTC)及减压。17例患者需要联合PTC和ERCP来置入支架。72例患者接受了剖腹手术,其中27例为局部进展期疾病。45例患者接受了可能治愈性切除。14例患者进行了肝外胆管切除,其中4例为R0切除。31例患者进行了胆管切除,包括部分肝切除术,其中19例为R0切除(P = 0.042)。19例患者出现术后并发症,30天内有4例死亡[肝功能不全/败血症(n = 3),重建门静脉血栓形成(n = 1)]。在R0切除的患者中,1年、3年和5年的累积生存率分别为83%、58%和41%,而R1切除的患者分别为71%、24%和24%(P = 0.021)。神经周围浸润阳性的患者总生存期较短(P = 0.066:无统计学意义)。淋巴结阳性组和阴性组的生存率无显著差异。接受肝切除的患者中位生存期长于仅接受胆管切除的患者(30个月对24个月,P = 0.43:无统计学意义)。
ERCP实现术前胆道减压的失败率较高,随后通过PTC实现了减压。切缘清晰与生存率提高相关,与肝外胆管切除相比,肝切除能更好地实现切缘清晰。I级淋巴结阳性对生存率无不利影响。